The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy

The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy

Introduction: The therapeutic effects of steroids in immunoglobulin A nephropathy (IgAN) global (TESTING) study reported that methylprednisolone reduces the risk of major kidney events in individuals with IgAN at high risk of disease progression compared to supportive care alone but is associated wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Dana Kim, Jicheng Lv, Michelle Hladunewich, Vivekanand Jha, Lai Seong Hooi, Helen Monaghan, Sana Shan, Heather N. Reich, Sean Barbour, Laurent Billot, Hong Zhang, Vlado Perkovic, Muh Geot Wong, Adeera Levin, Daniel Cattran, David W. Johnson, David Wheeler, Jürgen Flöge, Mark Woodward, Meg Jardine, Ming-hui Zhao, Rajiv Agarwal, Richard Glassock, Tak Mao Chan, Yangfeng Wu, Zhihong Liu
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:Kidney International Reports
Subjects:
corticosteroids
glomerulonephritis
IgA nephropathy
Online Access:http://www.sciencedirect.com/science/article/pii/S246802492401619X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S246802492401619X

Similar Items